Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -27.1% | -10.5% | 0 / 3 | +43.3% | +1.71 pp | -3.76 pp | +18.1% | 0.06 | 8.74 | 1.030 | +43,3% | 40,1 | −27,1% | 8.74 | 8.70 | +0,5% |
| Pts | 0 | 0 | 0 | 12 | 8 | 0 | 8 | 12 | 8 | |||||||
Valuation annotation:Price: 24.950 (close price on 2026-10-19)EPS (TTM): 2.853
Financial charts
1.Revenue & growth
VND bn1.030Q2/26
1.Revenue & growth
VND bn1.030Q2/26
2.Profit & growth
VND bn40,1Q2/26
3.Profit mix (Penman)
VND bn237Q2/26
4.Margins & cost structure
%22.3%Q2/26
5.Returns & cash cycle
% · days25.2%Q2/26
6.Earnings quality & cash
VND bn27,6Q2/26
7.Asset structure
VND bn1.569Q2/26
8.Funding & debt health
VND bn · times1.569Q2/26
9.Revenue backlog
VND bn9,84Q2/26
10.Valuation
times · %8,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %618Q2/26
Adjusted EPS growth, latest quarter
-27.1%
Average adjusted EPS growth, 3 quarters
-10.5%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26